Drug Shortage Report for SANDOZ OLANZAPINE

Last updated on 2021-11-24 History
Report ID 148970
Drug Identification Number 02310368
Brand name SANDOZ OLANZAPINE
Common or Proper name OLANZAPINE
Company Name SANDOZ CANADA INCORPORATED
Market Status MARKETED
Active Ingredient(s) OLANZAPINE
Strength(s) 5.0MG
Dosage form(s) TABLET
Route of administration ORAL ORAL
Packaging size 100FCT BO
ATC code N05AH
ATC description ANTIPSYCHOTICS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2021-11-08
Estimated end date 2022-01-14
Actual end date 2021-11-24
Shortage status Resolved
Updated date 2021-11-24
Company comments
Health Canada comments
Contact Address 110 RUE DE LAUZON
BOUCHERVILLE, QUEBEC
CANADA J4B 1E6
Company contact information 1 800-361-3062

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v5 2021-11-24 French Compare
v4 2021-11-24 English Compare
v3 2021-11-09 English Compare
v2 2021-11-08 French Compare
v1 2021-11-08 English Compare